![Mary Tanay RN on Twitter: "What does the future hold for head & neck cancers. An evening of the latest clinical research innovations, cancer care & treatment. Co-chairs: Prof Harrington & patient Mary Tanay RN on Twitter: "What does the future hold for head & neck cancers. An evening of the latest clinical research innovations, cancer care & treatment. Co-chairs: Prof Harrington & patient](https://pbs.twimg.com/media/EvqGQ8YXAAotCMU.jpg)
Mary Tanay RN on Twitter: "What does the future hold for head & neck cancers. An evening of the latest clinical research innovations, cancer care & treatment. Co-chairs: Prof Harrington & patient
![ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/images/default-source/default-album/icr-rmh-clarivate-highly-cited-researchers-2021-2-945x532.tmb-0945x532.jpg?sfvrsn=3d922b69_1)
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
![The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a](https://pbs.twimg.com/media/FCTe35EX0AAn_Tc.png)
The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a
![Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY](https://touchoncology.com/wp-content/uploads/sites/2/2022/01/ORD-4919_thumbnail.png)
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
![The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies](https://pbs.twimg.com/media/EksuaANXIAAxAzY.jpg)